Gretchen Haggerty Net Worth

The estimated Net Worth of Gretchen R Haggerty is at least $5.81 Million dollars as of 26 August 2019. Ms. Haggerty owns over 6,220 units of Teleflex stock worth over $4,323,789 and over the last 16 years she sold TFX stock worth over $1,246,086. In addition, she makes $239,395 as Independent Director at Teleflex.

Ms. Haggerty TFX stock SEC Form 4 insider trading

Gretchen has made over 12 trades of the Teleflex stock since 2004, according to the Form 4 filled with the SEC. Most recently she bought 6,220 units of TFX stock worth $257,508 on 26 August 2019.

The largest trade she’s ever made was exercising 132,000 units of Teleflex stock on 18 February 2004 worth over $2,756,160. On average, Gretchen trades about 10,478 units every 135 days since 2004. As of 26 August 2019 she still owns at least 12,860 units of Teleflex stock.

You can see the complete history of Ms. Haggerty stock trades at the bottom of the page.

Gretchen Haggerty biography

Gretchen R. Haggerty serves as v o fthe Company. Ms. Haggerty has been a director of Teleflex since 2016 and currently serves as a member of the Audit Committee. Ms. Haggerty retired in August 2013 after a 37-year career with United States Steel Corporation, an integrated global steel producer, and its predecessor, USX Corporation, which, in addition to its steel production, also conducted energy operations, principally through Marathon Oil Corporation. From March 2003 until her retirement, she served as Executive Vice President & Chief Financial Officer and also served as Chairman of the U. S. Steel & Carnegie Pension Fund and its Investment Committee. Earlier, she served in various financial executive positions at U. S. Steel and USX, beginning in November 1991 when she became Vice President & Treasurer. Ms. Haggerty is currently a director of USG Corporation and Johnson Controls International plc. Ms. Haggerty’s background in executive management of a large, complex global corporation enables her to share valuable perspectives with the Board on a wide range of financial and business matters. Her lengthy tenure as a financial executive renders her well-qualified to assist the Board with a variety of financial and budgeting matters, and in its oversight of our financial statements and internal controls.

What is the salary of Gretchen Haggerty?

As the Independent Director of Teleflex, the total compensation of Gretchen Haggerty at Teleflex is $239,395. There are 10 executives at Teleflex getting paid more, with Liam Kelly having the highest compensation of $6,108,490.

How old is Gretchen Haggerty?

Gretchen Haggerty is 63, she’s been the Independent Director of Teleflex since 2016. There are 5 older and 7 younger executives at Teleflex. The oldest executive at Teleflex, Inc. is Benson Smith, 71, who is the Non-Executive Chairman of the Board.

What’s Gretchen Haggerty’s mailing address?

Gretchen’s mailing address filed with the SEC is 5757 N GREEN BAY AVE, , MILWAUKEE, WI, 53209.

Insider trading at Teleflex

Over the last 16 years, insiders at Teleflex have traded over $16,519,759 worth of Teleflex stock and bought 3,250 units worth $797,630 . The most active insider traders include Gretchen R Haggerty, W Kim Foster, and Benson Smith. On average, Teleflex executives and independent directors trade stock every 15 days with the average trade being worth of $1,438,275. The most recent stock trade was executed by Benson Smith on 31 October 2019, trading 17,000 units of TFX stock currently worth $1,015,750.

What does Teleflex do?

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Vascular North America, Interventional North America, Anesthesia North America, Surgical North America, Europe, the Middle East and Africa (EMEA), Asia and Original Equipment Manufacturer and Development Services (OEM). The Vascular North America segment products facilitate a variety of critical care therapies, including the administration of intravenous medications and other therapies and the measurement of blood pressure and taking of blood samples through a single puncture site. The Interventional North America segment is comprised of the North American component of Vascular Solutions business. The Anesthesia North America segment provides products for clinicians working primarily in emergency rooms, surgery and critical care settings. The Surgical North America segment products are predominantly comprised of single-use products, including ligation clips and closure products; appliers and sutures used in a variety of surgical procedures; access ports used in minimally invasive laparoscopic surgical procedures, including robotic surgery, and fluid management products used for chest drainage. The EMEA segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves two end markets: hospitals and healthcare providers, and home health. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Teleflex was founded in 1943 and is headquartered in Wayne, PA.

Complete history of Ms. Haggerty stock trades at Johnson Controls International Plc, Teleflex, and United States Steel

Teleflex executives and stock owners

Teleflex executives and other stock owners filed with the SEC include:

  • Liam Kelly, President, Chief Executive Officer, Director
  • Thomas Powell, Chief Financial Officer, Executive Vice President
  • James Leyden, Vice President, General Counsel and Secretary
  • Cameron Hicks, Vice President – Global Human Resources
  • Karen Boylan, Vice President – Global Strategic Projects
  • Andrew Krakauer, Independent Director
  • Benson Smith, Non-Executive Chairman of the Board
  • George Babich, Lead Independent Director
  • Stuart Randle, Independent Director
  • Candace Duncan, Independent Director
  • Richard Packer, Independent Director
  • Gretchen Haggerty, Independent Director
  • Stephen Klasko, Independent Director
  • Jake Elguicze, Treasurer and Vice President Investor Relations
  • John Heinmiller, Independent Director
  • W Kim Foster, Director
  • Thomas Anthony Kennedy, Senior VP, Global Operations
  • John Deren, VP & Chief Accounting Officer
  • Patricia C Barron, Director
  • Jeffrey A Graves, Director
  • William Roland Cook, Director
  • Richard A Meier, Exec. Vice Pres. and CFO
  • James W Zug, Director
  • Charles Edward Williams, Corp. Controller and CAO
  • John B Suddarth, President-Aerospace
  • Jeffrey P Black, President, CEO
  • Vincent Northfield, President – Commercial
  • R Ernest Waaser, President – Medical
  • Harold L Iii Yoh, Director
  • Sigismundus W W Lubsen, Director
  • Seldeneck Judith M Von, Director
  • Matthew J Jennings, Sr. VP, Corp. Development
  • Kevin K Gordon, Vice Pres. Corporate
  • Julie Mcdowell, Sr. VP Corp. Communic.
  • John J Sickler, Vice Chairman
  • Randall P Gaboriault, Sr. Vice Pres. & Chf Info Off
  • Laurence G Miller, Sr.VP, General
  • Forrest R Whittaker, President – Medical
  • James W Eug, Director
  • Steven Kent Chance, Vice Pres., General
  • James W Stratton, Director
  • Clark D Handy, Exec.Vice Pres.
  • Martin S Headley, Exec. Vice Pres.
  • Lennox K Black, Non-Executive
  • James V Agnello, Corporate Controller
  • Donald Beckman, Director
  • Joan W Schwartz, Assoc.Gen’l Counsel
  • Thomas M Byrne, Assistant Treasurer
  • Joseph S Gonnella, Director
  • C Jeffrey Jacobs, Treasurer
  • Harold L Jr Zuber, Exec. Vice Pres. and
  • Janine Dusossoit,